Loading…

Acute Hemoptysis Following Cryoballoon Pulmonary Vein Isolation: A Multicenter Study

OBJECTIVESThis study sought to assess the incidence, procedural characteristics, contributing factors, and clinical outcome of cryoballoon-based pulmonary vein isolation (CB-PVI)-related hemoptysis in a multicenter study. BACKGROUNDHemoptysis has been described as a rare complication of CB-PVI. Howe...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Clinical electrophysiology 2020-07, Vol.6 (7), p.773-782
Main Authors: Vogler, Julia, Fink, Thomas, Sohns, Christian, Sommer, Philipp, Pott, Alexander, Dahme, Tillman, Rottner, Laura, Sciacca, Vanessa, Sieren, Malte Maria, Jacob, Fabian, Barkhausen, Jörg, Sano, Makoto, Eitel, Charlotte, Metzner, Andreas, Ouyang, Feifan, Kuck, Karl-Heinz, Tilz, Roland Richard, Heeger, Christian-Hendrik
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVESThis study sought to assess the incidence, procedural characteristics, contributing factors, and clinical outcome of cryoballoon-based pulmonary vein isolation (CB-PVI)-related hemoptysis in a multicenter study. BACKGROUNDHemoptysis has been described as a rare complication of CB-PVI. However, the precise mechanism and the etiology of this complication are poorly characterized. METHODSConsecutive patients undergoing CB-PVI for paroxysmal or persistent atrial fibrillation at 4 German hospitals were included in this observational analysis. RESULTSA total of 4,331 CB-PVI procedures were performed between 2006 and 2019. Fifteen patients (9 men, mean age 68.1 ± 9.8 years) developed acute hemoptysis during or within 24 h after CB-PVI, resulting in a hemoptysis frequency of 0.35%. Hemoptysis occurred in 6 of 720 procedures using the first-generation CB (0.83%) and in 9 of 3,611 procedures using the second-, third-, or fourth-generation CB (0.25%) (p = 0.015). Bronchoscopy was performed in 8 patients and showed bleeding exclusively due to mucosal injury or due to a coagulum at a bronchus adjacent to the ablation site. Hemoptysis resolved spontaneously without any long-term sequelae in all patients, except for a 92-year-old patient who died 13 days after CB-PVI due to pneumonia. No specific endobronchial treatment was necessary. CONCLUSIONSAcute hemoptysis after CB-PVI is a rare but potentially life-threatening complication that is usually self-limiting. Direct thermal injury of bronchi adjacent to a pulmonary vein seems to be the most likely mechanism.
ISSN:2405-5018
DOI:10.1016/j.jacep.2020.02.003